Search Results - "Boursier, J."

P1030 STATEMENT FOR REPORTING STUDIES OF DIAGNOSTIC ACCURACY ON LIVER FIBROSIS TESTS by Boursier, J

Get full text

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial by Ratziu, V., de Guevara, L., Safadi, R., Poordad, F., Fuster, F., Flores-Figueroa, J., Arrese, M., Fracanzani, Anna L., Ben Bashat, D., Lackner, K., Gorfine, T., Kadosh, S., Oren, R., Halperin, M., Hayardeny, L., Loomba, R., Friedman, S., Sanyal, Arun J.

“…Nonalcoholic steatohepatitis (NASH), a chronic liver disease without an approved therapy, is associated with lipotoxicity and insulin resistance and is a major…”
Get full text

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH by Boursier, J., Anty, R., Vonghia, L., Moal, V., Vanwolleghem, T., Canivet, C. M., Michalak, S., Bonnafous, S., Michielsen, P., Oberti, F., Iannelli, A., Van Gaal, L., Patouraux, S., Blanchet, O., Verrijken, A., Gual, P., Rousselet, M.‐C., Driessen, A., Hunault, G., Bertrais, S., Tran, A., Calès, P., Francque, S.

“…Summary Background The composite histological endpoint comprising nonalcoholic steatohepatitis (NASH) and NAFLD activity score ≥4 and advanced fibrosis (F ≥ 2)…”
Get full text

Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C – authors’ reply by Calès, P., Boursier, J.

“…Linked ContentThis article is linked to Trivedi and Lai, and Calès et al papers. To view these articles visit https://doi.org/10.1111/apt.14011 and…”
Get full text

Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis by Machado, M V, Michelotti, G A, Pereira, T de Almeida, Boursier, J, Kruger, L, Swiderska-Syn, M, Karaca, G, Xie, G, Guy, C D, Bohinc, B, Lindblom, K R, Johnson, E, Kornbluth, S, Diehl, A M

“…Caspase-2 is an initiator caspase involved in multiple apoptotic pathways, particularly in response to specific intracellular stressors (eg, DNA damage, ER…”
Get more information

Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software by Orcel, T., Chau, H. T., Turlin, B., Chaigneau, J., Bannier, E., Otal, P., Frampas, E., Leguen, A., Boulic, A., Saint-Jalmes, H., Aubé, C., Boursier, J., Bardou-Jacquet, E., Gandon, Y.

“…Objective To validate the proton density fat fraction (PDFF) obtained by the MRQuantif software from 2D chemical shift encoded MR (CSE–MR) data in comparison…”
Get full text

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination? by Calès, P., Boursier, J., Lebigot, J., Ledinghen, V., Aubé, C., Hubert, I., Oberti, F.

“…Summary Background In chronic hepatitis C, the European Association for the Study of the Liver and the Asociacion Latinoamericana para el Estudio del Higado…”
Get full text

Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults by Monseu, M, Dubois, S, Boursier, J, Aubé, C, Gagnadoux, F, Lefthériotis, G, Ducluzeau, P.-H

“…Abstract Aim This study aimed to determine the association between visceral adipose tissue (VAT), liver fat (LF) content, and other markers of the metabolic…”
Get full text

Screening of large esophageal varices by a simple algorithm of blood markers by Cales, P, Sacher-Huvelin, S, Valla, D, Bureau, C, Oberti, F, Boursier, J, Galmiche, J.P

Get full text

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C? by Cales, P, Boursier, J, de Ledinghen, V, Hubert, I, Oberti, F

Get full text

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C by Boursier, J., Brochard, C., Bertrais, S., Michalak, S., Gallois, Y., Fouchard‐Hubert, I., Oberti, F., Rousselet, M.‐C., Calès, P.

“…Summary Background Recent longitudinal studies have emphasised the prognostic value of noninvasive tests of liver fibrosis and cross‐sectional studies have…”
Get full text

Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance by Aubé, C, Bazeries, P, Lebigot, J, Cartier, V, Boursier, J

“…Abstract Although biological scores and elastography continue to yield the best results, imaging retains a crucial role in the diagnosis of liver fibrosis and…”
Get full text

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination? by Cales, P, Leroy, V, de Ledinghen, V, Boursier, J, Hubert, I, Oberti, F

Get full text

O017 : Effectiveness of treatment initiation based on fibrosis stage assessed by methods of fibrosis diagnosis in terms of 5-year incidence of morbi-mortality by Deuffic-Burban, S, Boursier, J, Leroy, V, Castera, L, Mathurin, P

Get full text

Non-Invasive Tests for the Diagnosis of Liver Fibrosis are also Prognostic Markers in Non-Alcoholic Fatty Liver Disease by Boursier, J, Lannes, A, Bertrais, S, Michalak, S, Oberti, F, Fouchard-Hubert, I, Calès, P

Get full text

Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis by Tsochatzis, E, Hiriart, J.B, Lupsor-Platon, M, Bronte, F, Boursier, J, Marra, F, Payance, A, Brodkin, E, Castera, L, Papatheodoridis, G, Arena, U, Cales, P, Calvaruso, V, de Ledinghen, V, Pinzani, M

Get full text

P1017 EVALUATION OF THE PROGNOSTIC VALUE OF NON-INVASIVE LIVER FIBROSIS TESTS TO PREDICT MORTALITY BY TIME-DEPENDENT ROC CURVES by Bertrais, S, Boursier, J, Oberti, F, Fouchard-Hubert, I, Calès, P

Get full text

O77 PROGNOSTIC MODELS FOR MORTALITY USING THE SUCCESSIVE VALUES OF NON-INVASIVE FIBROSIS TESTS IN PATIENTS WITH CHRONIC LIVER DISEASE by Bertrais, S, Boursier, J, Oberti, F, Fouchard-Hubert, I, Calès, P

Get full text

Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial by Ratziu, V, Wong, V.W.-S, Lanthier, N, Boursier, J, Alazawi, W, Kluwe, J, Genesca, J, Andreone, P, Serfaty, L, Skoien, R, Wiens, B.L, Vig, P, Lefebvre, E, Seyedkazemi, S, Kayali, Z, Poordad, F, Sanyal, A, Tacke, F, Goodman, Z

Get full text

High-throughput RNA sequencing unravels pathways associated with the progression of non-alcoholic liver disease by Govaere, O, Cockell, S.J, Vacca, M, Allison, M, Petta, S, Boursier, J, Bugianesi, E, Darlay, R, Cordell, H.J, Marra, F, Bedossa, P, Tiniakos, D, Vidal-Puig, A, Clément, K, Schattenberg, J.M, Ratziu, V, Anstee, Q.M, Daly, A.K

Get full text